All individual trials at Tarsus Pharmaceuticals, Inc.

An AllTrials project

All individual trials at Tarsus Pharmaceuticals, Inc.

3 out of 5

60.0%

$2,880,681

$0

Status	Sponsor	Trial ID	Title	Completion date	Days overdue
reported	Tarsus Pharmaceuticals, Inc.	NCT04475432	Randomized, Controlled, Multicenter, Double-Masked, Parallel, Phase 2b/3 Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis	2021-05-04
reported	Tarsus Pharmaceuticals, Inc.	NCT04784091	Randomized, Controlled, Multicenter, Double-Masked, Parallel, Phase 3 Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis	2022-05-09
reported-late	Tarsus Pharmaceuticals, Inc.	NCT05454956	Randomized, Double-Masked, Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of Meibomian Gland Dysfunction in Patients With Demodex Lid Infestation	2023-05-18	206
overdue	Tarsus Pharmaceuticals, Inc.	NCT06054217	Evaluating the Effect of Two Dosing Regimens of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With Demodex Lid Infestation	2024-06-15	72
overdue	Tarsus Pharmaceuticals, Inc.	NCT05387083	A Phase 2a, Randomized, Double-Blind, Placebo Controlled, Single-Center, Human Tick Kill Proof-of-Concept Study Evaluating the Safety, Tolerability, and Whole Blood Concentration of TP-05 (lotilaner) in Healthy Volunteers	2024-06-26	61
ongoing	Tarsus Pharmaceuticals, Inc.	NCT06182358	Randomized Controlled Trial to Evaluate the Impact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens Wearers	2025-01-27

Download this data